Our Mission
Levothyroxine. com exists to be the most accurate, well-organized levothyroxine information resource available to patients. That goal shapes every editorial decision we make.
We are not built around clicks, advertising performance, or search engine shortcuts. We are built around one question: what do patients who take levothyroxine actually need to understand, and what do the best available sources actually say? When those two things align clearly on the page, we’ve done our job.
Thyroid disease affects tens of millions of people. Levothyroxine is one of the most commonly prescribed medications in the United States. Patients deserve an information resource that treats them as capable adults and holds itself to a rigorous standard of accuracy.
Source Hierarchy
Not all sources are equal. We apply a strict hierarchy when researching and writing content. Claims on this site must be supported by at least one Tier 1–4 source. No exceptions.
Tier 1 – Regulatory (Highest Authority)
- FDA-approved prescribing information and drug labeling for levothyroxine products
- FDA drug safety communications and MedWatch notices
FDA prescribing information represents the regulatory standard for drug use in the United States. When FDA labeling speaks to a topic, dosing, contraindications, drug interactions, warnings, it takes precedence.
Tier 2, Clinical Consensus Guidelines
- American Thyroid Association (ATA) clinical practice guidelines
- Endocrine Society clinical practice guidelines
These organizations represent the professional consensus of endocrinologists and thyroid specialists. Their guidelines synthesize current evidence and expert judgment into practical clinical recommendations. When Tier 1 and Tier 2 sources align, we treat the topic as well-established.
Tier 3, Peer-Reviewed Research
- PubMed-indexed studies and systematic reviews
- Publications from major clinical journals including: The New England Journal of Medicine, Thyroid, The Journal of Clinical Endocrinology & Metabolism (JCEM), The BMJ, and JAMA
Peer-reviewed research informs the evidence base behind clinical guidelines. We use Tier 3 sources to explain the evidence behind recommendations, present areas of ongoing research or debate, and support claims not yet addressed by Tier 1 or 2 sources.
Tier 4, Established Medical Institutions
- Mayo Clinic
- Cleveland Clinic
- MedlinePlus (U. S. National Library of Medicine)
Patient-facing content from respected academic medical centers and government health portals is used to support plain-language explanations and corroborate higher-tier content.
What We Do Not Use
We do not use patient forums, unsourced health blogs, or commercial pharmacy websites as sources, regardless of how widely circulated their claims may be. We do not treat popular or frequently shared information as accurate unless it can be traced to a Tier 1–4 source.
How Articles Are Written
Every claim on this site is attributed to a specific source, cited inline, and linked directly to its origin, not to a secondary site that summarized it. If we cannot link a claim to a Tier 1–4 source, we do not publish it.
We write for patients, not for search engines. That means prioritizing clarity and accuracy over keyword density, and structuring pages around what patients actually need to know.
We do not generate original medical opinion. We do not conduct original research. We do not extrapolate beyond what authoritative sources have actually stated. When sources are uncertain or in genuine debate, we say so.
What We Don’t Do
To be explicit about what readers should not expect from this site:
- We do not make clinical recommendations tailored to individual patients
- We do not recommend specific levothyroxine brands or generic products for commercial reasons
- We do not accept payment from pharmaceutical companies, pharmacies, or any other commercial entity to include, exclude, promote, or suppress information
- We do not publish sponsored content dressed up as editorial content
Content Review Process
Published articles are not static. We review and update content when:
- FDA prescribing information is revised or a new safety communication is issued
- The ATA or Endocrine Society publishes new or updated clinical practice guidelines
- Significant new peer-reviewed evidence changes the established understanding of a topic
Each article displays a “last reviewed” date so readers know how current the information is.
Readers can flag potentially outdated information by contacting us via our contact form. We take those reports seriously and investigate them.
Transparency About Limitations
This site reflects what authoritative sources say as of each article’s last review date. Medicine is not static; guidelines are updated, new research is published, and clinical consensus evolves. This site should be used as a starting point for informed conversation with your healthcare provider, not as a final authority.
We also acknowledge that authoritative sources sometimes conflict, that evidence on certain topics is limited, and that some questions in thyroid medicine remain genuinely unsettled. Where that is the case, we say so clearly rather than presenting false certainty.
Corrections Policy
Factual errors reported via our contact form are investigated promptly. If an error is confirmed:
- The article is corrected as quickly as possible
- Significant corrections are noted at the bottom of the relevant article with a brief description of what changed and when
We do not quietly edit errors without acknowledgment when the correction is substantive.
No Conflicts of Interest
Levothyroxine. com does not receive payment from pharmaceutical manufacturers, pharmacy benefit managers, or any other commercial entity to include or promote specific products, brands, or services.
If this site includes any affiliate relationships, for example, links to pharmacy pricing comparison tools, those relationships are disclosed clearly on the relevant pages. Affiliate relationships do not influence editorial content. A source is never included because it pays us, and a source is never excluded because it doesn’t.
Last reviewed: March 2026. Questions about our editorial standards? Contact us us via our contact form.